News Genmab A/S Nasdaq

Stocks

GMAB

US3723032062

Biotechnology & Medical Research

Market Closed - Nasdaq 06:00:00 24/09/26 am AEST			5-day change	1st Jan Change
34.75 ^USD	-1.33%		+1.02%	+12.82%

03:07pm	Hansa Biopharma brings in two new board members	FW
02:55pm	Nordic stocks in North America, Astra Zeneca fell 1.2%	FW

All News

Mentions Relevance

23/09	Kempen raises target price for Genmab: 'petosemtamab could be the biggest share-price driver in a decade'	FW
22/09	Genmab A/S Presents at Bank of America Global Healthcare Conference 2026, Sep-22-2026 09:55 AM
17/09	Genmab A/S Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 03:00 PM
15/09	Genmab A/S Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 08:30 AM
09/09	Genmab A/S : has published its Articles of Association	PU
09/09	Capital Increase in Genmab as a Result of Employee Warrant Exercise	GL
08/09	Notice to Convene an Extraordinary General Meeting of Genmab A/S	GL
08/09	Barclays raises Genmab price target to 2,900 Danish kroner (2,500), reiterates overweight - BN	FW
01/09	Deutsche Bank raises price target for Genmab to 2,500 Danish kroner, reiterates buy	FW
31/08	Deutsche Bank raises Genmab price target to 2,500 Danish kroner (2,250), reiterates buy	FW
25/08	Genmab to Participate in Upcoming Investor Conferences	GL
20/08	AlphaValue/Baader Europe Downgrades Genmab to Add, Trims PT	MT
12/08	BNP Paribas Initiates Genmab at Outperform, With $40 Price Target	MT
12/08	Capital Increase in Genmab as a Result of Employee Warrant Exercise	GL
07/08	Genmab: Q2 beat reinforces the investment story; diversification efforts remain on course
07/08	Genmab A/S, H1 2026 Earnings Call, Aug 06, 2026
07/08	UBS raises Genmab price target to 2,700 Danish kroner (2,600), reiterates buy	FW
07/08	Genmab soars after raising its guidance
07/08	Analysts upbeat on Genmab after strong Q2	FW
07/08	Goldman Sachs raises Genmab target price to 2,400 Danish kroner (2,350), reiterates buy - BN	FW
07/08	TD Cowen raises Genmab price target to 2,892 Danish kroner (2,851), reiterates buy	FW
07/08	Jyske Bank raises Genmab target price to 2 350 Danish kroner (2 300), reiterates buy - BN	FW
07/08	Nordea raises its target price for Genmab to 2,083 Danish kroner (2,015), reiterates buy	FW
07/08	Genmab A/S Revises Earnings Guidance for the Year 2026	CI
07/08	Genmab A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI